ArticleFrontiers in cellular and infection microbiology2022

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.

Ju-Yeon Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.